Allied Health Research Grants

How to Apply: 

The purpose of the Allied Health Research Grant is to encourage allied health professionals to pursue research relevant to the areas of nephrology and organ donation, including clinical, health services, social, cultural, environmental and population health research. To be eligible for this grant the nominated principal applicant must been an allied health professional (see below). 

The award is for up to two years, to a maximum of $50,000/year. There must be a clearly demonstrated relevance of the project and its outcomes to the Mission of The Kidney Foundation. The research must be carried out in Canada.

Researchers with Biomedical or Basic projects are recommended to apply to the KFOC Biomedical Research Grants competition.

Post-Doctoral Fellows are encouraged to apply to the KRESCENT program.

External Deadline: 
Monday, October 15, 2018
Funding Source: 
External
Funding Level: 
Research

Boosting decent employment for Africa’s youth

Eligibility: 

Who can apply
An institution or a consortium of institutions that have a strong presence in sub-Saharan Africa, and with the following qualifications are invited to submit a concept note:
• Type of organization: Proposed research can be carried out by a research institution, research consortia or an NGO/implementing partner with strong research capacity. Donors, UN entities, multilateral organizations and independent research teams are not eligible to apply for this call.
• Collaboration: Research consortia not based in sub-Saharan Africa should have a demonstrable South-South or North-South collaboration, whichever the case may be. Priority will be given to consortia with a Southern institution lead. Partnerships between research organizations or consortia and implementing agencies are strongly encouraged.
• Countries of research focus: Proposed research must be carried out in one or more countries in sub-Saharan Africa. Priority will be given to those with a focus on low-income countries.

How to Apply: 

This Call is part a multi-funder research initiative on Boosting Decent Employment for Africa’s Youth, aimed at providing key insights, practical guidance, and tools to policy makers and practitioners to help realize aspirations for large-scale positive change. The research initiative is positioned within the Global Initiative on Decent Jobs for Youth, the overarching and inclusive effort endorsed by the UN Chief Executives Board for Coordination to scale up country-level action and impact on youth employment under the 2030 Agenda for Sustainable Development.

This Call aims to:
Strengthen the evidence base on sustainable and effective learning, skills development and market linkages, and active labour market measures to boost economic opportunities that facilitate the transition of youth into decent work.
• Foster learning and sharing of experiences through multi-stakeholder dialogue within and across countries.
• Provide opportunities for young people to actively engage in knowledge generation, policy dialogue, and initiatives that enhance their employability.

External Deadline: 
Monday, October 8, 2018
Funding Source: 
External
Funding Level: 
Research

CHS Research programs

How to Apply: 

SUBJECT:  1st CALL for Applications – Deadline: November 15, 2018 (Grant period of April 2019 to March 2020)

                   - Dream of a Cure, CHS Research Program

                   - Summer 2019 Dream of a Cure Studentships in Inherited Bleeding Disorders Research

                   - CHS/Pfizer Care Until Cure Research Program

                      - CHS/Novo Nordisk Psychosocial Research Programme

 

The Canadian Hemophilia Society (CHS) is proud to put out its call for applications for its research programs for the 2019-2020 grant period. The deadline to submit applications for all the programs is November 15, 2018. The eligibility criteria and conditions for all our research programs have been revised and updated. Of note, eligibility has been expanded as follows:

Ø  Dream of a Cure: the program is no longer limited to hemophilia A & B-related projects so that projects focusing on von Willebrand disease, rare factor deficiencies, platelet function disorders (and platelet pathophysiology) and other congenital and acquired bleeding disorders can be supported;

Ø  Dream of a Cure Studentshipsin Inherited Bleeding Disorders Research: similarly to our basic scientific research program, the studentships are no longer limited to hemophilia-related projects but include all inherited bleeding disorders. Furthermore, science students in any year of an undergraduate program can apply in addition to medical students in any year of training;

Ø  CHS/Pfizer Care Until Cure Research Program: the areas of interest to which investigators are encouraged to submit proposals has been expanded to include mild hemophilia A and B and Factor Utilization & Cost-effectiveness; all projects included but not limited to the list will be considered;

Ø  CHS/Novo Nordisk Psychosocial Research Programme: applications from Social Workers, Nurses, or Physiotherapists with professional experience in a hemophilia treatment centre (or other comparable settings in which care has been provided to people with hemophilia and other inherited bleeding disorders) or persons interested in the field of inherited bleeding disorders will be considered. Students in a PhD program in one of the allied health disciplines may also apply. Professionals who have appointments in universities and who can dedicate time to research are encouraged to apply. Professional experience in a hemophilia treatment centre is desirable but not required.

 

DREAM OF A CURE

 

Through funds provided by the Hemophilia Research Million Dollar Club and the CHS, the CHS provides basic scientific research grants and studentships aimed at developing treatments for hemophilia A and B, von Willebrand disease, rare factor deficiencies, platelet function disorders and ultimately, finding a cure.

 

Dream of a Cure, the CHS Research Program and the 2019 Dream of a Cure Summer Studentships in Inherited Bleeding Disorders Research application forms as well as the general criteria and conditions are available by accessing the CHS Web site at https://www.hemophilia.ca/chs-dream-of-a-cure-research-program/. For Dream of a Cure, individual grants will be awarded to researchers for one to two years for amounts up to $75,000 per year while support will be offered to interested Canadian medical or science students for up to 4 months for a maximum stipend of $6,000 per student. 

 

______________________________

 

 

CHS / PFIZER CARE UNTIL CURE RESEARCH PROGRAM

You will find at https://www.hemophilia.ca/the-chspfizer-care-until-cure-research-program/ the information for the CHS/Pfizer Care until Cure Research Program offered by the CHS in collaboration with Pfizer Canada. This program allows Canadian investigators to conduct research on medical and psychosocial aspects of bleeding disorders. Grants for one to two years with a maximum of $75,000 per year will be awarded for clinical research, including outcome evaluation, in fields relevant to improving the health and the quality of life for persons with Hemophilia, persons with von Willebrand disease or other inherited bleeding disorders, persons with related conditions such as HIV or hepatitis C infection, and carriers of an inherited bleeding disorder.

 
______________________________

 

 

CHS/Novo Nordisk canada Psychosocial Research Programme

 

The CHS/Novo Nordisk Canada Psychosocial Research Program was created to engage hemophilia program professionals/graduate students from the allied health disciplines (ie. Nursing, Physiotherapy & Social Work) in research activities addressed to understanding the psychosocial impact of hemophilia and other inherited bleeding disorders and to improve the quality of life of persons and families whose lives are affected by these disorders.

 

The primary intent of this program is to offer one or two $20,000 research grants, to a maximum of $40,000 for one year.

 

Depending upon the number and quality of applications, funding for more than two research grant could be offered within the allotted total budget stated above.

The major portion of each grant would be to cover the research time for the successful candidate(s), including the time for research assistants. A small amount can be devoted to project expenses.

 

Multidisciplinary Collaboration:
Collaboration with multidisciplinary care providers and/or between two or more hemophilia centres is accepted and encouraged. Collaboration efforts may include, for example, social work, physical therapy and genetics. It thus may be possible for a hemophilia centre team to jointly submit a cooperative research project. Additionally, inter-regional applications will be considered.
 
Applications and Deadline:
A letter of intent should be submitted to the Canadian Hemophilia Society by November 15, 2018. The letter, with a maximum of two pages, should identify the researcher, the organization and include a summary description of the intended area of research.


The CHS Peer Review Committee will invite a limited number of candidates to submit a more detailed proposal by January 17, 2019 in order to make a final selection. Grants will be offered for a one-year period to begin in April 2019.

 

More detailed information is available by accessing the CHS Web site at https://www.hemophilia.ca/the-chsnovo-nordisk-psychosocial-research-program/

External Deadline: 
Thursday, November 15, 2018
Funding Source: 
External
Funding Level: 
Doctoral
Masters
Research
Undergraduate

Team Grant : Human Immunology Initiative: Research Teams

How to Apply: 

The Human Immunology Research Teams are expected to:

  • Generate new scientific knowledge that will advance our understanding of human immunology as it relates to autoimmune diseases, with appropriate consideration of sex-related mechanisms, in order to improve the health of Canadians living with autoimmune diseases.
  • Leverage the Standardization Core by encouraging collaboration with the Core and utilization of the Core’s research methodologies where possible.
  • Develop and strengthen research capacity by providing training opportunities to the next generation of human immunology researchers in the field of autoimmune diseases.
External Deadline: 
Tuesday, October 16, 2018
Funding Source: 
External
Funding Level: 
Research

Other : Planning & Dissemination Grants – ICS

How to Apply: 

The specific objectives of this funding opportunity are:

  • to support planning activities, partnership development and/or increasing understanding of the health research landscape that will contribute to the advancement of research consistent with the mandate of CIHR; and/or;
  • to support dissemination events/activities that focus on the communication of health research evidence to the appropriate researcher and/or knowledge user audience(s), tailoring the message and medium as appropriate.
External Deadline: 
Tuesday, September 11, 2018
Funding Source: 
External
Funding Level: 
Research

Operating Grant : Geroscience Demonstration Grants

How to Apply: 

The Geroscience Demonstration Grants are expected to:

  • Accelerate, catalyze, and build capacity for research on the early prevention of chronic diseases in aging using a geroscience approach
  • Support the creation of new knowledge to improve our understanding of the relationship between mechanisms in the biological processes of aging and the development of one or several chronic conditions (e.g., diabetes, cancer, neurodegenerative diseases, arthritis, cardio-respiratory diseases)
  • Support research using a geroscience approach that could lead to potential clinical impacts.
External Deadline: 
Thursday, November 15, 2018
Funding Source: 
External
Funding Level: 
Research

Defense Health Program Department of Defense Psychological Health/Traumatic Brain Injury Research Program: FY18 PHTBIRP Joint DoD and VA Long-term Impact of Military-relevant Brain Injury Consortium (LIMBIC)

How to Apply: 

The FY18 Defense Appropriation provides $125 million (M) to the Department of Defense Psychological Health/Traumatic Brain Injury Research Program (PH/TBIRP) to support critical PH- and TBI-related research and development efforts to benefit Service members, Veterans, and other beneficiaries of the military health system.  As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency, J9 Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Program Announcement/Funding Opportunity is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Materiel Command (USAMRMC).  The CDMRP provides PH/TBIRP execution management support for DHP core research program areas, including the Joint Program Committee 6/ Combat Casualty Care Research Program (JPC-6/CCCRP).  JPC-6/CCCRP provides strategic oversight for the PH/TBI funds associated with this funding Program Announcement.  The Defense Health Agency is working in collaboration with the U.S. Department of Veterans Affairs (VA) and other Federal agencies on research efforts to improve the lives of Service members and Veterans affected by traumatic brain injury, posttraumatic stress disorder, and other mental health conditions.

The FY18 PH/TBIRP Program Announcement and General Application Instructions for the following award mechanism is posted on the Grants.gov website.

http://cdmrp.army.mil/funding/phtbi

 

FY18 PHTBIRP Joint DoD and VA Long-term Impact of Military-relevant Brain Injury Consortium (LIMBIC) – Preproposal due October 8

  • Independent investigators at all academic levels (or equivalent)
  • Supports a consortium conducting a single large longitudinal study and supporting sub-studies to analyze a large TBI cohort to include Service member and Veterans.
  • Applicants must be able to demonstrate the ability to enroll relevant cohorts, including military and Veteran populations, and follow them over time.
  • Applicants must address the Required Research Elements outlined in the Program Announcement.
  • Applications should describe a single large longitudinal cohort study and a minimum of four related sub-studies.
  • All projects shall be limited to clinical and epidemiological research.
  • Clinical trials are not supported.
  • Coordinating Center and study sites must apply through a single application.
  • Preproposal is required; application submission is by invitation only.
  • Maximum allowable costs (direct and indirect) are $25M via the DoD.
  • Up to an additional $5M per year for 5 years will be provided by the VA to VA sites, depending on availability of funds.
  • Maximum period of performance is 5 years.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

 

For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the PH/TBIRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk
301-682-5507
help@eBrap.org

External Deadline: 
Monday, October 8, 2018
Funding Source: 
External
Funding Level: 
Research

Department of Defense Psychological Health/Traumatic Brain Injury Research Program

How to Apply: 

The FY18 Defense Appropriation provides $125 million (M) to the Department of Defense Psychological Health/Traumatic Brain Injury Research Program (PH/TBIRP) to support critical traumatic brain injury (TBI)- and psychological health (PH)-related research and development efforts to benefit Service members, Veterans, and other beneficiaries of the military health system.  As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA) J9, Research and Development Directorate, manages the Defense Health Program’s Research, Development, Test, and Evaluation appropriation.  The U.S. Army Medical Research and Materiel Command (USAMRMC) Congressionally Directed Medical Research Programs (CDMRP) provides execution management support for DHA research program areas, including the Joint Program Committee-8/Clinical and Rehabilitative Medicine Research Program (JPC-8/CRMRP).  The managing agent for this Program Announcement is the CDMRP with strategic oversight from the JPC-8/CRMRP.

The FY18/19 PH/TBIRP will solicit research applications for the following CTRR Focus Areas:

Mechanisms of Recovery following isolated or cumulative TBI(s) in Service member-relevant injuries:  Clinical research in human subjects that measures physiologic responses to cognitive rehabilitation with the intent to better understand how rehabilitation remediates cognitive or sensorimotor deficits, and ultimately to optimize rehabilitation prescription.

Ecological Assessment:  Investigation of outcome measures focused on military-specific tasks that inform return-to-duty/participation decisions following rehabilitation in patients with TBI. 

Cognitive Rehabilitation:  Evaluation of rehabilitation intervention effectiveness in remediating cognitive impairments and functional limitations after TBI. 

https://www.grants.gov/web/grants/search-grants.html

 

CTRR – Clinical Research Award (CTRR-CRA) – Preproposal due September 24, 2018

Independent investigators at all academic levels (or equivalent)

·        Supports applied and translational research to advance the development of knowledge and materiel products for rehabilitation and restoration of function following TBI.

·        Supported research can include preclinical studies using human subjects or samples and observational or mechanistic clinical research studies.

·        Clinical trials are not allowed.

·        Preclinical research using animals is not allowed.

·        Must address one or more FY18/19 PH/TBIRP CTRR Focus Areas.

Preproposal is required; application submission is by invitation only.

·       Maximum funding of $2.0M for total costs (includes direct and indirect costs).

·       Maximum period of performance is years.

 

 

CTRR – Clinical Trial Award (CTRR-CTA) – Preproposal due September 24, 2018

Independent investigators at all academic levels (or equivalent)

·        Supports small, single-site, Phase I clinical trials to advance the development of knowledge and materiel products for rehabilitation and restoration of function following TBI in Service members, Veterans, and other individuals.

·        Interventions should be limited, existing, and manualized.  Studies may include seeking to optimize dosing in existing interventions.

·        Preclinical studies are not allowed.

·        Must address one or more FY18/19 PH/TBIRP CTRR Focus Areas.

Preproposal is required; application submission is by invitation only.

·       Maximum funding of $2.0M for total costs (includes direct and indirect costs).

·       Maximum period of performance is 3 years.

 

CTRR – Clinical Trial Development Award (CTRR-CTDA) – Preproposal due September 24, 2018

Independent investigators at all academic levels (or equivalent)

·       Supports design and development of the necessary research resources that will serve as a foundation for investigator-initiated clinical trials as described above under CTRR – Clinical Trial Award (CTRR-CTA)

·       Final supporting studies required for approval of Investigational New Drug Applications/Investigational Device Exemptions (IND/IDE-enabling) are allowed.  Other preclinical studies are not allowed. 

·       Clinical trials are not allowed within the period of performance of the CTRR-CTDA.

·       Must address one or more FY18/19 PH/TBIRP CTRR Focus Areas.

Preproposal is required; application submission is by invitation only.

·      Maximum funding of $200,000 for total costs (includes direct and indirect costs).

·       Maximum period of performance is 12 months.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism is also on Grants.gov.  A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

 

For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the PH/TBIRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk

301-682-5507
help@eBRap.org

External Deadline: 
Monday, September 24, 2018
Funding Source: 
External
Funding Level: 
Research

Dr. R. K. Dewar Medical Research Grant Fund

Eligibility: 

To apply for a grant from the Thunder Bay Community Foundation, you must be qualified donee as per the Canada Revenue Agency. Below is a list of qualified donees:

  • a registered charity (including a registered national arts service organization);
  • a registered Canadian amateur athletic association;
  • a registered housing corporation resident in Canada constituted exclusively to provide low-cost housing for the aged;
  • a registered Canadian municipality;
  • a registered municipal or public body performing a function of government in Canada;
  • a registered university outside Canada that is prescribed to be a university, the student body of which ordinarily includes students from Canada;
  • a registered charitable organization outside Canada to which Her Majesty in right of Canada has made a gift;
  • Her Majesty in right of Canada, a province, or a territory; and
  • the United Nations and its agencies.

If you received a grant in the previous year, you must complete all obligations to be able to apply for new grants.

How to Apply: 

The Dr. R. K. Dewar Medical Research Grant was established in 1987 by Ms. Helen Dewar to honour the life and work of her brother Dr. Robert Kerr Dewar. Dr. Dewar had faith in the future and progress of medical science and had a keen interest in cutting edge research of his day. He was particularly interested in Neuro-Regeneration and Molecular Biology. When selecting R. K. Dewar Grants our Selection Committee looks for the following elements in successful proposals:

  • Addresses a small research project or marketing for a health care charity
  • Makes an impact on Health Care in Thunder Bay
  • Seeks to assist in the future progress of medicine.
  • Are organized and well written.
External Deadline: 
Friday, October 12, 2018
Funding Source: 
External
Funding Level: 
Research

Proposals for General Scientific Activities

How to Apply: 

The Fields Institute is currently accepting proposals for the October 15, 2018 competition cycle.

Deadlines

Deadlines for general scientific activity proposal applications are February 15, June 15, and October 15 of each year. A lead time of at least nine (9) months is requested between the proposal application deadline and the date of the event. Applications are reviewed after each deadline.

Proposals requesting funding of up to $25,000 are considered by the Institute's Directorate and decisions are normally announced within six (6) weeks of each deadline. Proposals requesting over $25,000 will be considered by the Institute's Scientific Advisory Panel (SAP) and should be submitted by the February 15 and October 15 deadlines only, with decisions normally announced by early June or December of each year.

Proposals for General Scientific Activities

General scientific activities (GSA) generally consist of a period of one day to one month of concentrated activity in topics of current research interest in the mathematical sciences and should include opportunities for the involvement of young scientists and graduate students. A large number of general scientific activities are scheduled for each academic year. Topics supported through general scientific activities are often newly emerging areas in the mathematical sciences in Canada and add breadth to the range of research supported by the Fields Institute. The activities may be in the form of workshops, seminars, conferences and/or summer schools.

The GSA program is the principal method by which Fields engages a wider community to input into its scientific programs and an important way for Fields to stay connected to Principal Sponsoring and Affiliate Universities. Our proposal mechanism was devised to invite these activities. The Directorate, consulting with referees and members of the SAP, makes decisions about support following a rigorous selection process. Applicants may apply for financial and/or logistical support from Fields. Logistical support options are described here

External Deadline: 
Monday, October 15, 2018
Funding Source: 
External
Funding Level: 
Research

Pages